Aeglea BioTherapeutics Announces Update to Corporate Structure to Increase Operational Efficiency
Streamlining of organization to focus on near-term deliverables for pegtarviliase in Homocystinuria and long-term value creation Cortney Caudill, M.B.A., has been promoted to the newly created role of chief product officer to increase focus and efficiency in the advancement of clinical…
Comments Off on Aeglea BioTherapeutics Announces Update to Corporate Structure to Increase Operational Efficiency